series demonstrating preserved osmolar regulation, anterior pituitary endocrine regulation, pressor responses to pain, preserved or transiently preserved EEG and evoked potential function. The evidence strongly suggests that the clinical evaluation as practised today can not perfectly define the absence of all brain biologic functions. Conversely evidence that the preservation of these vestiges of full human function correlate with either survival or recovery is also nonexistent. While a cleaner definition may be possible, it seems that more practical goals are occupying the efforts of North American physicians: 1. minimizing the failure to recognize drug intoxication, 2. performing apnoea testing in a valid but safe manner.
To this end the American Academy of Neurology has recently produced Practice Parameters jor Determining Brain Death in Adults l • The goal of this guideline was not to provide another prescriptive definition but rather to identify the current complexity of the brain death evaluation and to provide simple statements of how the determination is made in most instances. It was hoped that the complicated area of apnoea testing would be made safer and more easily interpreted by the use of preoxygenation and the development of monitoring standards. What these new guidelines will achieve remains to be realized.
From a community or social perspective the current and future uncertainties in the diagnosis of brain death are a minor issue.
A prospective assessment of clinical and laboratory test validity in "nearly brain dead" patients supported in a uniform manner would be ideal to eliminate the current medical uncertainties. The cost of such a study would be significant in dollars and emotional dimensions. Presently we can correctly state the level of evidence that supports the current definitions and act with a significant degree of diagnostic comfort. The vast majority of the American public has accepted that the diagnosis is a technical matter and that the best medical judgement is a reasonable standard. From a clinical perspective the current clinical definition is both functional and effective. It permits cessation of useless Anaesthesia and Intensive Care, Vol. 23, No. I, February, 1995 therapy, allows the natural progression to an acceptance of loss, and enables the opportunity for organ donation.
I have not seen indications of significant community mistrust of the brain death criteria or of the organ donation procedures in daily practice. The issue with the greatest potential to create mistrust on the part of patients' families is one of communication and medical disclosure. We will lose trust if we continue to portray the current criteria as a guarantee of biologic certainty rather than a prescription for rational behaviour. My experience in American medicine would suggest Anaesthesia and Intensive Care, Vol. 13, No. I, February, 1995 that we should work on making the current criteria safer and more uniform, and on educating our peer physicians to be more explicit in explaining the factual bases of our practice to our patients' families. It is very likely that there is more individual and community utility in the dissemination and utilization of our current criteria than in the reworking of the definition.
